BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9571000)

  • 1. Concomitant endometrial hyperplasia in patients with endometrial carcinoma.
    Gücer F; Reich O; Tamussino K; Bader AA; Pieber D; Schöll W; Haas J; Petru E
    Gynecol Oncol; 1998 Apr; 69(1):64-8. PubMed ID: 9571000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multivariate analysis of prognostic factors in endometrial carcinoma].
    Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
    Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of endometrial carcinoma patients aged 45 years and younger].
    Gao JS; Shen K; Lang JH; Huang HF; Pan LY; Wu M; Jin Y; Chen QH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):159-61. PubMed ID: 15130373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
    Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
    Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial carcinoma associated with hyperplasia.
    Kaku T; Tsukamoto N; Hachisuga T; Tsuruchi N; Sakai K; Hirakawa T; Amada S; Saito T; Kamura T; Nakano H
    Gynecol Oncol; 1996 Jan; 60(1):22-5. PubMed ID: 8557221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
    Salvesen HB; Iversen OE; Akslen LA
    Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
    Citron JR; Sutton H; Yamada SD; Mehta N; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1432-8. PubMed ID: 15275729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma: treatment implications.
    Aquino-Parsons C; Lim P; Wong F; Mildenberger M
    Gynecol Oncol; 1998 Oct; 71(1):83-6. PubMed ID: 9784324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosomal DNA methylation in patients with endometrial carcinoma: an independent prognostic marker.
    Powell MA; Mutch DG; Rader JS; Herzog TJ; Huang TH; Goodfellow PJ
    Cancer; 2002 Jun; 94(11):2941-52. PubMed ID: 12115383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer.
    DuBeshter B; Estler K; Altobelli K; McDonald S; Glantz C; Angel C
    Gynecol Oncol; 2004 Aug; 94(2):383-6. PubMed ID: 15297176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial metaplasia associated with endometrial carcinoma.
    Kaku T; Tsukamoto N; Tsuruchi N; Sugihara K; Kamura T; Nakano H
    Obstet Gynecol; 1992 Nov; 80(5):812-6. PubMed ID: 1407921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma.
    Sakuragi N; Hareyama H; Todo Y; Yamada H; Yamamoto R; Fujino T; Sagawa T; Fujimoto S
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):311-6. PubMed ID: 10746848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences.
    Soslow RA; Bissonnette JP; Wilton A; Ferguson SE; Alektiar KM; Duska LR; Oliva E
    Am J Surg Pathol; 2007 Jul; 31(7):979-87. PubMed ID: 17592263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study.
    Sutton G; Axelrod JH; Bundy BN; Roy T; Homesley HD; Malfetano JH; Mychalczak BR; King ME
    Gynecol Oncol; 2005 Jun; 97(3):755-63. PubMed ID: 15913742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Uterine papillary serous carcinoma and papillary endometrial carcinoma: analysis of clinical biological behaviors of 56 cases].
    Sun X; Shi S; Sheng X
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):8-11. PubMed ID: 8758810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
    Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
    Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.